Molecular Advances in Melanoma Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 May 2025 | Viewed by 2274
Special Issue Editor
Interests: cell signaling; melanoma; photobiology; skin cancer; cell metabolism; melaninognesis; cell motility; ionizing radiation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Melanoma is a major global health issue and represents up to 5.5% of all skin cancers worldwide. It arises from melanocytes found in the epidermis, and chronic inflammation, genetic factors and sun exposure contribute to the formation of melanoma. Malignant melanoma spreads rapidly and can swiftly invade nearby tissues, progressing to the lymph nodes and metastasizing to other organs. Early diagnosis and treatment are crucial to patient survival. Various systemic drug therapies target the immunogenic aspects of this cancer. Traditional immunotherapy, such as TNFα and immune checkpoint inhibitors, is also widely used in the treatment of melanomas. Recently, significant interest from multidisciplinary research groups worldwide has emerged in seeking to utilize nonconventional remedies, such as cannabinoids, to treat melanoma.
The aim of this Special Issue is to extend the knowledge of current remedies employed in the treatment of melanoma. Methodological studies focusing on new models as well as research techniques used to study these aspects are also welcome.
Dr. Terrence Piva
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanoma
- anti-cancer
- immunotherapy
- targeted therapy
- signaling pathway
- Polyphenolic compounds
- cannabinoids
- pharmacotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
